CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: August-03-17
Credit Expiration Date: August-03-18


David J. Lederer, MD, MS
Associate Professor of Medicine
Co-Director, Interstitial Lung Disease Program
Columbia University Medical Center
New York, NY

Kevin R. Flaherty, MD, MS
Professor of Medicine
Director, University of Michigan Interstitial Lung Disease Program
Chair, Pulmonary Fibrosis Foundation Clinical Care Network/Registry Steering Committee
Ann Arbor, MI

Sonye K. Danoff, MD, PhD
Associate Professor of Medicine
Co-Director, Johns Hopkins ILD/IPF Program
Associate Director, Johns Hopkins Myositis Center
Baltimore, MD

Credit Hours

1.0 AMA PRA Category 1 Credit


Video Roundtable

Program Description

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment.

Program Developer/Facilitator


Target Audience

Pulmonologists, internal medicine specialists, primary care clinicians, radiologists, and other clinicians who encounter ILD.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Discuss advances in ILD diagnosis and assessment.
  2. Review evidence-based treatment strategies for ILD.
  3. Discuss the optimal management of common comorbidities associated with ILD.


All faculty and staff involved in the planning, review or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All additional planning committee members, reviewers, Purdue and MCM Education staff have nothing to disclose.

Dr. Lederer discloses the following conflicts of interest.
Grants/Research Support: Boehringer Ingelheim, Global Blood Therapeutics, Fibrogen
Consultant: Roche, Patara, Immuneworks
Advisory Board Membership: Global Blood Therapeutics, Fibrogen, Sanofi Genzyme, Philips Respironics
Editorial Board Involvement: American Thoracic Society

Dr. Flaherty discloses the following conflicts of interest.
Grants/Research Support: Boehringer Ingelheim, Roche/Genentech
Consultant: Boehringer Ingelheim, Roche/Genentech, Veractye, Fibrogen

Dr. Danoff discloses the following conflicts of interest.
Grants/Research Support: Genentech/Roche
Advisory Board Membership: Boehringer Ingelheim, Global Blood Therapeutics

Purdue University requires all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.

In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Credit Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Purdue University College of Pharmacy and MCM Education. Purdue University is accredited by the ACCME to provide continuing medical education for physicians.

Purdue University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support Statements

This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.


Completion Instructions

  1. Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
  2. Accessing Activity:
    * Click "Start Program"
    * Take the pre-test
    * Review the activity
    * Take the post-test and score 80%
    * You are allowed a total of 3 attempts
    * Complete the evaluation
    * View, print, or save a CME certificate verifying your credit/participation in this activity

Certificate Fee


There is no charge for CME credit.


©2017 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Purdue University, or Boehringer Ingelheim. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu